Zeid Khitan is a Nephrology physician affiliated with Marshall University. OpenAlex indexes 67 publications with 971 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1690 Medical Center Drive
Huntington, WV 257019300
Telephone
304-526-2532Provider last certified this registry record 18 Nov 2021.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Calliditas Therapeutics US Inc.Program year20251 payment
- Ardelyx, Inc.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71%Loop diuretic12.8%Furosemide62%Torsemide38%Part D≥37 patientsAngiotensin receptor blocker (ARB)11.4%Losartan Potassium94%Valsartan6%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
16.7%Vitamin D3 Analog6.4%Calcitriol100%Part D≥33 patientsSGLT2 inhibitor5%Jardiance100%Part D≥22 patients+ 3 more classes in this area
Genitourinary & hormones
4.7%alpha-Adrenergic Blocker3.5%Tamsulosin Hcl100%Part D≥19 patients5-alpha Reductase Inhibitor1.3%Finasteride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevalence and risk factors of metabolic dysfunction–associated steatotic liver disease in patients with inflammatory bowel disease
European Journal of Gastroenterology & Hepatology
2025 - Chronic kidney disease and cardiac remodeling potentiate cognitive impairment progression: disentangling the sex-specific cross talk of kidney-heart-brain axis
American Journal of Physiology-Heart and Circulatory Physiology
2025 - Complement-Mediated Hemolytic Uremic Syndrome Due to MCP/CD46 Mutation: A Case Report
Journal of Investigative Medicine High Impact Case Reports
2025 - Acute Interstitial Nephritis (AIN) Following Bee Stings: A Rare Etiology of Progressive Kidney Failure
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
David Gozal, MD
Marshall University
Matias Valsecchi, MD
Marshall University
Khalid Abozguia, MD, PhD
Marshall University
James Gigantelli, MD
Marshall University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”